Skip to main content

ProShare Advisors LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1357955 BETHESDA, MD

Position in PTGX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,333,425
+$77,268 QoQ
Shares Held
10,878
-8.7% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 341 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. PTGX ranks #12 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,333,425 10,878
2026-03-31 $1,256,157 11,918
2025-12-31 $1,230,096 14,084
2025-09-30 $876,012 13,187
2025-06-30 $849,831 15,376
2025-03-31 $810,416 16,758
2024-12-31 $789,640 20,457
2024-09-30 $705,645 15,681
2024-06-30 $390,505 11,270
2024-03-31 $415,000 14,345
2023-12-31 $301,277 13,139
2023-09-30 $186,515 11,182
2023-06-30 $297,053 10,755
2023-03-31 $204,378 8,886
2022-03-31 $317,288 13,399
2021-12-31 $563,923 16,489
2021-09-30 $281,606 15,892
2021-06-30 $835,710 18,621
2021-03-31 $398,005 15,367
2020-12-31 $259,560 12,875